Natasha Archer, MD
Basic profileDana-Farber/Boston Children's Cancer and Blood Disorders Center
Natasha Archer is an Oncology physician affiliated with Dana-Farber/Boston Children's Cancer and Blood Disorders Center. OpenAlex indexes 93 publications with 821 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Brookline Ave
Boston, MA 022155418
Telephone
617-632-3352Provider last certified this registry record 8 Sept 2025.
Clinical trials
- Optimal Timing of Ketamine Initiation for SCD Pain
Sponsor: Boston Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20252 payments
- Novo Nordisk IncProgram year20252 payments
- Agios Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes
Boston Children'S Hospital
FY2024$167,940K08DK123386 - Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes
Boston Children'S Hospital
FY2023$167,940K08DK123386 - Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes
Boston Children'S Hospital
FY2022$167,940K08DK123386
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pilot of the International Hemoglobinopathy Research Network for a multiethnic genome-wide association study
Blood Global Hematology
2026 - Genetic Modifiers Associated with Vaso-Occlusive Crises and Acute Pain Phenomena in Sickle Cell Disease: A Scoping Review
International Journal of Molecular Sciences
2025 - Ethical and regulatory requirements for conducting researcher-driven large-scale multinational genetic haematological studies: the INHERENT experience
Health Research Policy and Systems
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dubois, MD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Rani George, MD, PhD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Suzanne Shusterman, MD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Yoav Binenbaum, MD, PhD
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”